Medexus Pharmaceuticals (MDP.TO) is a rare disease pharmaceutical company with a portfolio of innovative and high value rare disease products positioning the company for growth in the next decade…
Best Canadian Biotech
Sixth Wave Innovations (SIXW.C) fired up its fund raising engines on Friday, looking to trade units for CAD$6 million, according to a press release. The company is planning to…
“Molecularly imprinted polymers (MIPs) are synthetic polymers with a predetermined selectivity for a given analyte, or group of structurally related compounds, making them ideal materials to be used in…
Sixth Wave Innovations (SIXW.C) research team finished the first molecular imprint of the SARS-CoV-2 virus using its AMIPs process and technology today, according to a press release. The AMIPS…
Buckle up everyone, and get excited – let’s break down Medexus’ latest press release with all its technical details. This is a two-parter, because Medexus not only has closed…
Dr. Houghton – a Director and Research Chair holder at Li Ka Shing – just won a Nobel Prize….
SIXW is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs)….
Sixth Wave is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs)….